Sci Transl Med

Pediatricians’ natural immunity inspires novel antibody cocktails against respiratory viruses

February 23, 2026

A new study in Science Translational Medicine reports that antibodies derived from pediatricians—who acquire repeated, low‑level exposure to respiratory syncytial virus (RSV) and human metapneumovirus (hMPV)—can be engineered into antibody cocktails that effectively neutralize both pathogens. Investigators isolated broadly reactive antibodies from clinicians with long-term occupational exposure, mapped their conserved viral epitopes, and combined them into multi‑antibody formulations. In preclinical models, these cocktails provided robust protection against RSV and hMPV challenge, suggesting a potential pathway toward dual‑acting passive immunization, particularly for infants, older adults, and immunocompromised populations at high risk of severe disease.

Clinical takeaway: While not yet ready for clinical use, these findings point to future passive immunization options that could offer simultaneous protection against RSV and hMPV—an area to watch as new monoclonal strategies advance toward human trials.

Source:

Zhai H, et al. (2026, February 18). Sci Transl Med. Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV. https://pubmed.ncbi.nlm.nih.gov/41706868/